Chronic Chagas' heart disease: A disease on its way to becoming a worldwide health problem: Epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine

Heart Failure Reviews

Volumn 17, Issue 1, 2012, Pages 45-64

  Muñoz Saravia, Silvia Gilka ^a,b   Haberland, Annekathrin ^b   Wallukat, Gerd ^b   Schimke, Ingolf ^b  

^a Santa Barbara Hospital Sucre   (Bolivia)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Autoantibodies; Chagas' heart disease; Heart marker; Inflammation marker; Oxidative stress marker; Trypanosoma cruzi

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AUTOANTIBODY; BENZNIDAZOLE; BRAIN NATRIURETIC PEPTIDE; CD4 ANTIGEN; CD8 ANTIGEN; G PROTEIN COUPLED RECEPTOR; GLUTATHIONE PEROXIDASE; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 8; MANGANESE SUPEROXIDE DISMUTASE; NIFURTIMOX; SOLUBLE INTERLEUKIN 2 RECEPTOR; SUPEROXIDE DISMUTASE; TROPONIN I; TROPONIN T; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; APHERESIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CHAGAS DISEASE; CHOLINERGIC SYSTEM; CHRONIC CHAGAS DISEASE; CYTOTOXICITY; HEART MUSCLE CELL; HUMAN; IN VIVO STUDY; LYMPHOCYTE ACTIVATION; MEGACOLON; MEGAESOPHAGUS; MORBIDITY; MORTALITY; NONHUMAN; OXIDATIVE STRESS; PARASITE CONTROL; PARASITE TRANSMISSION; PATHOGENESIS; RISK ASSESSMENT; SYMPTOMATOLOGY; TRYPANOSOMA CRUZI;

CHAGAS CARDIOMYOPATHY; HUMANS; TRYPANOCIDAL AGENTS; TRYPANOSOMA CRUZI; WORLD HEALTH;

EID: 84655176655     PISSN: 13824147     EISSN: 15737322     Source Type: Journal    
DOI: 10.1007/s10741-010-9211-5     Document Type: Article

References (171)

1. A Prata 1994 Chagas' disease Infect Dis Clin North Am 8 61 76 8021449 1:STN:280:DyaK2c3pt1OgsA%3D%3D (Pubitemid 24114817)
2. A Prata 2001 Clinical and epidemiological aspects of Chagas disease Lancet Infect Dis 1 92 100 11871482 1:STN:280:DC%2BD387js1Olsg%3D%3D 10.1016/S1473-3099(01)00065-2 (Pubitemid 33586044)
3. AR Teixeira N Nitz MC Guimaro C Gomes CA Santos-Buch 2006 Chagas disease Posgrad Med 82 788 798 1:CAS:528:DC%2BD2sXhsFyqsrs%3D 10.1136/pgmj.2006.047357 (Pubitemid 46101925)
4. AR Teixeira RJ Nascimento NR Sturm 2006 Evolution and pathology in Chagas disease-a review Mem Inst Oswaldo Cruz 101 463 491 17072450 10.1590/S0074-02762006000500001 (Pubitemid 44304084)
5. JA Marin-Neto E Cunha-Nerto BC Maciel MV Simoes 2007 Pathogenesis of chronic Chagas heart disease Circulation 115 1109 1123 17339569 10.1161/CIRCULATIONAHA.106.624296 (Pubitemid 46679556)
6. A Moncayo 2003 Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries Mem Inst Oswaldo Cruz 98 577 591 12973523 10.1590/S0074- 02762003000500001 (Pubitemid 38019577)
7. PL Dorn L Perniciaro MJ Yabsley DM Roelling G Balsamo J Diaz D Wesson 2007 Autochthonous transmission of Trypanosoma cruzi, Louisiana Emerg Infect Dis 13 605 607 17553277 10.3201/eid1304.061002 (Pubitemid 46525117)
8. JC Dias CJ Schofield EM Machado AJ Fernandes 2005 Ticks, ivermectin, and experimental Chagas disease Mem Inst Oswldo Cruz 100 829 832 10.1590/S0074-02762005000800002 (Pubitemid 43213808)
9. JC Dias AC Silveira CJ Schofield 2002 The impact of Chagas disease control in Latin America-a review Mem Inst Oswaldo Cruz 97 603 612 12219120 1:STN:280:DC%2BD38vnslyrtg%3D%3D 10.1590/S0074-02762002000500002 (Pubitemid 135746072)
10. A Moncayo MI Ortiz Yanine 2006 An update on Chagas disease (human American trypanosomiasis Ann Trop Med Parasitol 100 663 677 17227647 1:STN:280:DC%2BD2s%2FivFeruw%3D%3D 10.1179/136485906X112248 (Pubitemid 46940906)
11. JC Dias A Prata D Correia 2008 Problems and perspectives for Chagas disease control: in search of realistic analysis Rev Soc Bras Med Trop 41 193 196 18545843 (Pubitemid 351872401)
12. Salvatella R (2007, July 6) Achievments in controlling Chagas disease in Latin America. In: Conference Geneva (WHO)
13. Dias JC (2001) Epidemiology of Chagas' disease. In: Wendel S, Brener Z, Camargo ME, Rassi A (eds) Chagas' disease (American trypanosomiasis): its impact on transfusion and clinical medicine. Sociedade Brasileira de Hematologia e Hemoterapia, Sao Paulo, pp 49-80
14. C Bern SP Montgomery 2009 An estimate of the burden of Chagas disease in the United States Clin Infect Dis 49 e52 e54 19640226 10.1086/605091
15. RA Guerri-Guttenberg DR Grana G Ambrosio J Milei 2008 Chagas cardiomyopathy: Europe is not spared! Eur Heart J 29 2587 2591 18840880 10.1093/eurheartj/ehn424
16. GA Schmunis ZE Yadon 2010 Chagas disease: a Latin American health problem becoming a world health problem Acta Trop 115 14 21 19932071 10.1016/j.actatropica.2009.11.003
17. GA Schmunis 1999 Risk of Chagas disease through transfusions in the Americans Medicina (B Aires) 59 125 134
18. JCP Dias CJ Schofield 1999 The evolution of Chagas disease (American trypanosomiasis) control after 90 years since Carlos Chagas discovery Men Inst Oswaldo Cruz 94 suppl 1 103 121 10.1590/S0074-02761999000700011 (Pubitemid 129584478)
19. Centers for Disease Control, Prevention (CDC) 2007 Blood donor screening for Chagas disease-United States, 2006-2007 MMWR Morb Mortal Wkly Rep 56 141 143
20. M Piron M Verges J Munoz N Casamitjana S Sanz RM Maymó JM Hernández L Puig M Portús J Gascón S Sauleda 2008 Seroprevalence of Trypanosoma cruzi infection in at-risk blood donors in Catalonia (Spain) Transfusion 48 1862 1868 18522707 10.1111/j.1537-2995.2008. 01789.x
21. RA Guerri-Guttenberg A Ciannameo C Di Girolamo JJ Milei 2009 Chagas disease: an emerging public health problem in Italy? Infez Med 17 5 13 19359818 1:STN:280:DC%2BD1Mvis1Wlug%3D%3D
22. Société de pathologie exotique 2010 Chagas disease. American trypanosomiasis. Recommendation for non-endemic zones Med Trop (Mars) 70 131 132
23. E Azogue 1993 Women and congenital Chagas' disease in Santa Cruz, Bolivia: epidemiological and sociocultural aspects Soc Sci Med 37 503 511 8211262 1:STN:280:DyaK2c%2FisVWisg%3D%3D 10.1016/0277-9536(93)90285-C (Pubitemid 23235901)
24. C Riera A Guarro HE Kassab JM Jorba M Castro R Angrill M Gállego R Fisa C Martin A Lobato M Portús 2006 Congenital transmission of Trypanosoma cruzi in Europe (Spain): a case report Am J Trop Med Hyg 75 1078 1081 17172369 (Pubitemid 351627484)
25. AM Macedo CR Machado RP Oliveira SD Pena 2004 Trypanosoma cruzi: genetic structure of populations and relevance of genetic variability to the pathogenesis of Chagas disease Mem Inst Oswaldo Cruz 99 1 12 15057339 1:CAS:528:DC%2BD2cXjtVKmurk%3D 10.1590/S0074-02762004000100001 (Pubitemid 38406258)
26. S Manoel-Caetano Fda AE Silva 2007 Implications of genetic variability of Trypanosoma cruzi for the pathogenesis of Chagas disease Cad Saude Publica 23 2263 2274 17891288 10.1590/S0102-311X2007001000002
27. Torrico F, Castro M (2002) Enfermedad de Chagas. In: Medicina tropical, CD-Rom, ITGPRESS; ISBN 90-76070-237
28. DE Ochs VS Hnilica DR Moser JK Smith LV Kirchhoff 1996 Postmortem diagnosis of autochthonous acute chagasic myocarditis by polymerase chain reaction amplification of a species-specific DNA sequence of Trypanosoma cruzi Am J Trop Med Hyg 54 526 529 8644910 1:STN:280:DyaK283ktVWlsw%3D%3D (Pubitemid 26162249)
29. N Gironés H Cuervo M Fresno 2005 Trypanosoma cruzi-induced molecular mimicry and Chagas' disease Curr Top Microbiol Immunol 296 89 123 16323421 10.1007/3-540-30791-5-6 (Pubitemid 41667263)
30. S Kumar RL Tarleton 1998 The relative contribution of antibody production and CD8 + T cell function to immune control of Trypanosoma cruzi Parasite Immunol 20 207 216 9651921 1:CAS:528:DyaK1cXmtFKrsrc%3D 10.1046/j.1365-3024. 1998.00154.x (Pubitemid 28255393)
31. JC Aliberti MA Cardoso GA Martins RT Gazzinelli LQ Vieira JS Silva 1996 Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophage in response to live trypomastigotes Infect Immun 64 1961 1967 8675294 1:CAS:528:DyaK28Xjt1OqtL8%3D (Pubitemid 26165653)
32. M Fresno M Kopf L Rivas 1997 Cytokines and infectious diseases Immunol Today 18 56 58 9057352 1:CAS:528:DyaK2sXhtlGrur0%3D 10.1016/S0167-5699(96)30069- 8 (Pubitemid 27107095)
33. RT Gazzinelli IP Oswald S Hieny SL James A Sher 1992 The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukibn-10 and transforming growth factor-beta Eur J Immunol 22 2501 2506 1396957 1:CAS:528:DyaK3sXlsFKl 10.1002/eji.1830221006
34. MA Munoz-Fernandez MA Fernandez M Fresno 1992 Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism Eur J Immunol 22 301 307 1537373 1:CAS:528:DyaK38XhslWqtbg%3D 10.1002/eji.1830220203
35. JS Silva PJ Morrissey KH Grabstein KM Mohler D Anderson SG Reed 1992 Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection J Exp Med 175 169 174 1730915 1:CAS:528:DyaK38XlslSqsA%3D%3D 10.1084/jem.175.1.169
36. F Torrico H Heremans MT Rivera E van Marck A Billiau Y Carlier 1991 Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice J Immunol 146 3626 3632 1902858 1:CAS:528:DyaK3MXltlersLw%3D
37. C Holscher G Kohler U Muller 1998 Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase Infect Immun 66 1208 1215 9488415 1:CAS:528:DyaK1cXhtlSrsrs%3D (Pubitemid 28101166)
38. E Castanos-Velez S Maerlan LM Osorio F Aberg P Biberfeld A Orn ME Rottenberg 1998 Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice Infect Immun 66 2960 2968 9596773 1:CAS:528: DyaK1cXjs1ehsrc%3D (Pubitemid 28261809)
39. D Martin R Tarleton 2004 Generation, specificity, and function of CD8 + T cells in Trypanosoma cruzi infection Immunol Rev 201 304 317 15361249 1:CAS:528:DC%2BD2cXpt1GnsLg%3D 10.1111/j.0105-2896.2004.00183.x (Pubitemid 39318460)
40. HA Avila DS Sigman LM Cohen RC Millikan L Simpson 1991 Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas' disease Mol Biochem Parasitol 48 211 221 1662334 1:CAS:528:DyaK3MXmtVSgsrg%3D 10.1016/0166-6851(91) 90116-N
41. LV Kirchhoff JR Votava DE Ochs DR Moser 1996 Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi J Clin Microbiol 34 1171 1175 8727897 1:CAS:528:DyaK28XjtVWmt7Y%3D (Pubitemid 26126886)
42. CL Karp PG Auwaerter 2007 Coinfection with HIV and Tropical Infectious Diseases. I. Protozoal Pathogens Clin Infect Dis 45 1208 1213 17918086 10.1086/522181 (Pubitemid 47580323)
43. C Mady AV de Moraes N Galiano LV Décourt 1982 Hemodynamic study of the indeterminate form of Chagas' disease Arq Bras Cardiol 38 271 275 6820272 1:STN:280:DyaL3s7nslGrtQ%3D%3D (Pubitemid 12026066)
44. RE Sicca SM Gonzalez Cappa OP Sanz G Mirkin 1995 Peripheral nervous system involvement in human and experimental chronic American trypanosomiasis Bull Soc Pathol Exot 88 156 163
45. ER Lopes 1999 Sudden death in patients with Chagas disease Mem Inst Oswaldo Cruz 94 Suppl 1 321 324 10677747 10.1590/S0074-02761999000700061 (Pubitemid 129584520)
46. LO Andrade CR Machado E Chiari SD Pena AM Macedo 2002 Trypanosoma cruzi: role of host genetic background in the differential tissue distribution of parasite clonal populations Exp Parasitol 100 269 275 12128054 10.1016/S0014-4894(02)00024-3 (Pubitemid 36279297)
47. M Tibayrenc 2007 Human genetic diversity and the epidemiology of parasitic and other transmissible diseases Adv Parasitol 64 377 462 17499103 10.1016/S0065-308X(06)64004-9 (Pubitemid 46711210)
48. Z Layrisse MT Fernandez S Montagnani M Matos O Balbas F Herrera IA Colorado F Catalioti H Acquatella 2000 HLA-C*03 is a risk factor for cardiomyopathy in Chagas disease Human Immunol 61 925 929 1:CAS:528: DC%2BD3cXosVWksrw%3D 10.1016/S0198-8859(00)00161-0
49. S Garcia Borras L Racca C Cotorruelo C Biondi J Beloscar A Racca 2009 Distribution of HLA-DRB1 alleles in Argentinien patients with Chagas' disease cardiomyopathy Immunol Invest 38 268 275 19811437 10.1080/08820130902766589 1:CAS:528:DC%2BD1MXpvV2jtL0%3D
50. KC Fae SA Drigo E Cunha-Neto B Ianni C Mady J Kalil AC Goldberg 2000 HLA and -myosin heavy chain do not influence susceptibility to Chagas' disease cardiomyopathy Microbes Infect 2 745 751 10955954 1:CAS:528:DC%2BD3cXlvFelsr0%3D 10.1016/S1286-4579(00)00501-3 (Pubitemid 30451215)
51. S Yacoub EJ Birks Z Slavik M Henein 2003 Early detection of myocardial dysfunction in Chagas disease using novel echocardiographic indices Trans R Soc Trop Med Hyg 97 528 534 15307418 10.1016/S0035-9203(03)80016-0 (Pubitemid 40590086)
52. S Dubner E Schapachnik AR Riera E Valero 2008 Chagas disease: state-of-the-art of diagnosis and management Cardiol J 15 493 504 19039752
53. C Bern SP Montgomery BL Herwaldt A Rassi Jr JA Marin-Neto RO Dantas JH Maguire H Acquatella C Morillo LV Kirchhoff RH Gilman PA Reyes R Salvatella AC Moore 2007 Evaluation and treatment of Chags disease in the United States: a systematic review JAMA 298 2171 2181 18000201 1:CAS:528:DC%2BD2sXhtlSksbrI 10.1001/jama.298.18.2171 (Pubitemid 350106656)
54. RJ Viotti C Vigliano S Laucella B Lococo M Petti G Bertocchi B Ruiz Vera H Armenti 2004 Value of echocardiography for diagnosis and prognosis of chronic Chagas disease cardiomyopathy without heart failure Heart 90 655 660 15145872 1:STN:280:DC%2BD2c3kslSisQ%3D%3D 10.1136/hrt.2003.018960 (Pubitemid 38668541)
55. H Acuatella 2007 Echocardiography in Chagas heart disease Circulation 115 1124 1131 10.1161/CIRCULATIONAHA.106.627323 (Pubitemid 46673173)
56. ML Shehata EB Turkbey J Vogel-Claussen DA Bluemke 2008 Role of cardiac magnetic resonance imaging in assessment of nonischemic cardiomyopathies Top Magn Reson Imaging 19 43 57 18690160 10.1097/RMR.0b013e31816fcb22
57. HB Tanowitz FS Machado LA Jelicks J Shirani AC de Carvalho DC Spray SM Factor LV Kirchhoff LM Weiss 2009 Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease) Prog Cardiovasc Dis 51 524 539 19410685 10.1016/j.pcad.2009.02.001
58. MS Braga L Lauria-Pires ER Argañaraz RJ Nascimento AR Teixeira 2000 Persistent infections in chronic Chagas' disease patients treated with anti-Trypanosoma cruzi nitroderivatives Rev Inst Med Trop Sao Paulo 42 157 161 10887376 1:STN:280:DC%2BD3czpvVyjtw%3D%3D 10.1590/S0036-46652000000300009 (Pubitemid 32229947)
59. L Lauria-Pires MS Braga AC Vexenat N Nitz A Simões-Barbosa DL Tinoco AR Teixeira 2000 Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives Am J Trop Med Hyg 63 111 118 11388500 1:CAS:528:DC%2BD3MXktlygsLY%3D (Pubitemid 32488345)
60. N Hernández-Becerril A Nava PA Reyes VM Monteón 2001 IgG subclases reactivity to Trypanosoma cruzi in chronic chagasic patients Arch Cardiol Mex 71 199 205 11665655
61. WL Tafuri TA Maria ER Lopes E Chapadeiro 1973 Electron microscopy of the myocardium in human trypanosomiasis cruzi Rev Inst Med Trop Sao Paulo 15 347 370 4209017 1:STN:280:DyaE2c7nvVWjsw%3D%3D
62. MA Rossi 2001 Connective tissue skeleton in the normal left ventricle and in hypertensive left ventricular hypertrophy and chronic chagasic myocarditis Med Sci Monit 7 820 832 11433216 1:STN:280:DC%2BD3MvitlOitA%3D%3D (Pubitemid 32691767)
63. JS Oliveira 1985 A natural human model of intrinsic heart nervous system denervation: Chagas' cardiopathy Am Heart J 110 1092 1098 3904376 1:STN:280:DyaL28%2FkslGjtA%3D%3D 10.1016/0002-8703(85)90222-4 (Pubitemid 16052613)
64. M Py R Pedrosa J Silveira A Medeiros C Andre 2009 Neurological manifestations in Chagas disease without cardiac dysfunction: correlation between dysfunction of the parasympathetic nervous system and white matter lesions in the brain J Neuroimaging 19 332 336 19021835 10.1111/j.1552-6569. 2008.00305.x
65. RH Gallerano JJ Marr RR Sosa 1990 Therapeutic efficacy of allopurinol in patients with chronic Chagas' disease Am J Trop Med Hyg 43 159 166 2117857 1:STN:280:DyaK3czlvVaqtg%3D%3D (Pubitemid 20268883)
66. G Wallukat E Nissen R Morwinski J Müller 2000 Autoantibodies against the beta- and muscarinic receptors in cardiomyopathy Herz 25 261 266 10904849 1:STN:280:DC%2BD3cvnt1CnsA%3D%3D 10.1007/s000590050017 (Pubitemid 30422174)
67. G Wallukat GS Munoz Saravia A Haberland S Bartel R Araujo G Valda D Duchen I Diaz Ramirez AC Borges I Schimke 2010 Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients J Am Coll Cardiol 55 463 468 20117461 1:CAS:528: DC%2BC3cXivVaqt7c%3D 10.1016/j.jacc.2009.06.064
68. SB Felix A Staudt WV Dorffel V Stangl K Merkel M Pohl WD Döcke S Morgera HH Neumayer KD Wernecke G Wallukat K Stangl 2000 Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study J Am Coll Cardiol 35 1590 1598 10807465 1:STN:280:DC%2BD3c3msFOntw%3D%3D 10.1016/S0735-1097(00) 00568-4 (Pubitemid 30307505)
69. J Müller G Wallukat M Dandel H Bieda K Brandes S Spiegelsberger E Nissen R Kunze R Hetzer 2000 Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy Circulation 101 385 391 10653829 (Pubitemid 30067394)
70. V Labovsky CR Smulski K Gómez G Levy MJ Levin 2007 Anti-beta 1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease Clin Exp Immunol 148 440 449 17419712 1:CAS:528:DC%2BD2sXnsVOnsbw%3D 10.1111/j.1365-2249.2007.03381.x (Pubitemid 46701041)
71. C Trimpert LR Herda LG Eckerle S Pohle C Müller M Landsberger SB Felix A Staudt 2010 Immunoadsorption in dilated cardiomyopathy: long-term reduction of cardiodepressant antibodies Eur J Clin Invest 40 685 691 20546018 1:CAS:528:DC%2BC3cXhtVKis73M 10.1111/j.1365-2362.2010.02314.x
72. EP 2197900 (2010, Aug 5) 1-Adrenozeptor-Antikörper inhibierende, mutierte, doppeltcyklisierte Rezeptorpeptide
73. Haberland A, Wallukat G, Dahmen C, Kage A, Schimke I (2010) JACC (submitted)
74. DM Engman JS Leon 2002 Pathogenesis of Chagas heart disease: role of autoimmunity Acta Trop 81 123 132 11801219 10.1016/S0001-706X(01)00202-9 (Pubitemid 34093802)
75. E Cunha-Neto AM Bilate KV Hyland SG Fonseca J Kalil DM Engman 2006 Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry Autoimmunity 39 41 54 16455581 1:CAS:528:DC%2BD28XhtVGns7Y%3D 10.1080/08916930500485002 (Pubitemid 43878519)
76. DD Reis RT Gazzinelli G Gazzinelli DG Colley 1993 Antibodies to Trypanosoma cruzi express idiotypic patterns that can differentiate between patients with asymptomatic or severe Chagas' disease J Immunol 150 1611 1618 8432996 1:CAS:528:DyaK3sXitFWitLY%3D (Pubitemid 23127451)
77. Wallukat G, Nissen E, Müller J, Brinckmann R, Schimke I, Kunze R (2002) The pathophysiological role of autoantibodies directed to G-protein coupled receptors and therapeutic strategies of antibody removal. In: Brinckmann R, Kunze R (eds) G-protein coupled receptors and autoantibodies. Pabst Science Publishers, Legerich, pp 7-47
78. R Elies I Ferrari G Wallukat D Lebesgue P Chiale M Elizari M Rosenbaum J Hoebeke MJ Levin 1996 Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas' disease J Immunol 157 4203 4211 8892658 1:CAS:528:DyaK28XmsF2qtbo%3D (Pubitemid 126449335)
79. MO Masuda M Levin SF De Oliveira PC Dos Santos Costa PL Bergami NA Dos Santos Almeida RC Pedrosa I Ferrari J Hoebeke AC Campos de Carvalho 1998 Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens FASEB J 12 1551 1558 9806764 1:CAS:528:DyaK1cXnt1Olsbg%3D (Pubitemid 28506724)
80. PR Gouldson C Higgs RE Smith MK Dean GV Gkoutos CA Reynolds 2000 Dimerization and domain swapping in G-protein-coupled receptors: a computational study Neuropsychopharmacology 23 S60 S77 11008068 1:CAS:528: DC%2BD3cXmslKqtLs%3D 10.1016/S0893-133X(00)00153-6
81. MJ Levin J Hoebeke 2008 Cross-talk between anti-beta1-adrenoceptor antibodies in dilated cardiomyopathy and Chagas' heart disease Autoimmunity 41 429 433 18781468 1:CAS:528:DC%2BD1cXhtFajsbvI 10.1080/08916930802031702
82. R Jahns V Boivin L Hein S Triebel CE Angermann G Ertl MJ Lohse 2004 Direct evidence for a beta 1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy J Clin Invest 113 1419 1429 15146239 1:CAS:528:DC%2BD2cXktlCltrs%3D (Pubitemid 39071697)
83. R Jahns V Boivin MJ Lohse 2006 Beta 1-adrenergic receptor-directed autoimmunity as a cause of dilated cardiomyopathy in rats Int J Cardiol 112 7 14 16872696 10.1016/j.ijcard.2006.05.008 (Pubitemid 44247194)
84. R Elies LX Fu P Eftekhari G Wallukat W Schulze C Granier A Hjalmarson J Hoebeke 1998 Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor Eur J Biochem 251 659 666 9490038 1:STN:280:DyaK1c7kvFKrsA%3D%3D 10.1046/j.1432-1327.1998.2510659.x (Pubitemid 28108959)
85. T Christ E Wettwer D Dobrev E Adolph M Knaut G Wallukat U Ravens 2001 Autoantibodies against the beta1 adrenoceptor from patients with dilated cardiomyopathy prolong action potential duration and enhance contractility in isolated cardiomyocytes J Mol Cell Cardiol 33 1515 1525 11448139 1:CAS:528:DC%2BD3MXltVenuro%3D 10.1006/jmcc.2001.1414 (Pubitemid 32681669)
86. PA Chiale I Ferrari E Mahler MA Vallazza MV Elizari MB Rosenbaum MJ Levin 2000 Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction Circulation 103 1765 1771 (Pubitemid 32291414)
87. L Sterin-Borda C Perez Leiros M Wald G Cremaschi E Borda 1988 Antibodies to beta 1 beta 2 adrenoreceptors in Chagas' disease Clin Exp Immunol 74 349 354 2853016 1:STN:280:DyaL1M7mvVyguw%3D%3D
88. R Jahns V Boivin T Krapf G Wallukat F Boege MJ Lohse 2000 Modulation of beta1-adrenoceptor activity by domain-specific antibodies and heart failure-associated autoantibodies J Am Coll Cardiol 36 1280 1287 11028484 1:CAS:528:DC%2BD3cXnvV2hu74%3D 10.1016/S0735-1097(00)00881-0
89. Y Magnusson G Wallukat F Waagstein A Hjalmarson J Hoebeke 1994 Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of autoantibodies against the beta 1-adrenoceptor with positive chronotropic effect Circulation 89 2760 2767 8205690 1:STN:280:DyaK2c3msFegsQ%3D%3D (Pubitemid 24173697)
90. EG Krause S Bartel I Beyerdorfer G Wallukat 1996 Activation of cyclic AMP-dependent protein kinase in cardiomyocytes by anti-beta 1-adrenoceptor autoantibodies from patients with idiopathic dilated cardiomyopathy Blood Press Suppl 3 37 40 8973767 1:STN:280:DyaK2s7ivFamuw%3D%3D (Pubitemid 26402714)
91. CE Ford NP Skiba H Bae Y Daaka E Reuveny LR Shekter R Rosal G Weng CS Yang R Iyengar RJ Miller LY Jan RJ Lefkowitz HE Hamm 1998 Molecular basis for interactions of G protein betagamma subunits with effectors Science 280 1271 1274 9596582 1:CAS:528:DyaK1cXjt1GqtbY%3D 10.1126/science.280.5367.1271 (Pubitemid 28269623)
92. JC Goin CP Leiros E Borda L Sterin-Borda 1997 Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications FASEB J 11 77 83 9034169 1:CAS:528:DyaK2sXhtFaksLk%3D (Pubitemid 27076327)
93. JC Goin L Sterin-Borda CR Bilder LM Varrica G Iantorno MC Ríos E Borda 1999 Functional implications of circulatin muscarinic cholinergic receptor autoantibodies in Chagasic patients with achalasia Gastroenterology 117 798 805 10500061 1:STN:280:DyaK1MvjtF2jsw%3D%3D 10.1016/S0016-5085(99)70337-9 (Pubitemid 29468221)
94. L Sterin-Borda JC Goin CR Bilder G Iantorno AC Hernando E Borda 2001 Interaction of human chagasic IgG with human colon muscarínico acetylcholine receptor: molecular and functional evidence Gut 49 699 705 11600475 1:CAS:528:DC%2BD3MXosVWqtrY%3D 10.1136/gut.49.5.699 (Pubitemid 32989209)
95. CP Leiros L Sterin-Borda ES Borda JC Goin MM Hosey 1997 Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas' disease J Biol Chem 272 12989 12993 9148906 1:CAS:528:DyaK2sXjtlalt7g%3D 10.1074/jbc.272.20.12989 (Pubitemid 27216716)
96. AY Pinto SA Valente C Valente Vda AG Ferreira Junior JR Coura 2008 Acute phase of Chagas disease in the Brazilian Amazon region: study of 233 cases from Pará, Amapá and Maranhão observed between 1988 and 2005 Rev Soc Bras Med Trop 41 602 614 19142440 10.1590/S0037-86822008000600011
97. C Diaz V Nussenzweig A Gonzalez 1992 An improved polymerase chain reaction assay to detect Trypanosoma cruzi in blood Am J Trop Med Hyg 46 616 623 1599057 1:CAS:528:DyaK38Xls1Cqs7Y%3D
98. AR Vago AM Macedo SJ Adad DD Reis R Corrêa-Oliveira 1996 PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease Lancet 348 891 892 8826826 1:STN:280:DyaK28visVejsQ%3D%3D 10.1016/S0140-6736(05)64761-7 (Pubitemid 26320915)
99. MM Otani E Vinelli LV Kirchhoff A del Pozo A Sands G Vercauteren EC Sabino 2009 WHO comparative evaluation of serologic assays for Chagas disease Transfusion 49 1076 1082 19290995 10.1111/j.1537-2995.2009.02107.x
100. DA Campbell SJ Westenberger NR Sturm 2004 The determinants of Chagas disease: connecting parasite and host genetics Curr Mol Med 4 549 562 15357207 1:CAS:528:DC%2BD2cXmvVKmtro%3D 10.2174/1566524043360249 (Pubitemid 39172362)
101. SG Munoz Saravia A Haberland S Bartel R Araujo G Valda D Duchen I Diaz Ramirez AC Borges G Wallukat I Schimke 2010 Distinct patterns of autoantibodies against G-protein coupled receptors in Chagas' cardiomyopathy and megacolon: their potential impact for early risk assessment in asymptomatic Chagas' patients J Am Coll Cardiol 56 526 527 20670767 10.1016/j.jacc.2010.02.057
102. JC Goin E Borda R Auger R Storino L Sterni-Borda 1999 Cardiac M(2) muscarinic cholinoceptor activation by human chagasic autoantibodies: association with bradycardia Heart 82 273 278 10455074 1:STN:280: DyaK1Mzoslahsg%3D%3D (Pubitemid 29429596)
103. G Wallukat A Wollenberger 1987 Effects of the serum gamma globulin fraction of patients with allergic asthma and dilated cardiomyopathy on chromotropic beta adrenoceptor function in cultured neonatal rat heart myocytes Biomed Biochim Acta 46 S634 S639 2449194 1:CAS:528:DyaL1cXitVelsQ%3D%3D
104. G Wallukat S Podlowski E Nissen R Morwinski C Csonka A Tosaki IE Blasig 2003 Functional and structural characterization of anti-beta1-adrenoceptor autoantibodies of spontaneously hypertensive rats Mol Cell Biochem 251 67 75 14575306 1:CAS:528:DC%2BD3sXovFCgtbo%3D 10.1023/A:1025469515963 (Pubitemid 37220711)
105. VO Nikolaev V Boivin S Störk CE Angermann G Ertl MJ Lohse R Jahns 2007 A novel fluorescence method for the rapid detection of functional beta1-adrenergic receptor autoantibodies in heart failure J Am Coll Cardiol 50 423 431 17662395 1:CAS:528:DC%2BD2sXot1ymt7o%3D 10.1016/j.jacc.2007.03.051 (Pubitemid 47088126)
106. R Jahns V Boivin C Siegmund G Inselmann MJ Lohse F Boege 1999 Autoantibodies activating human beta1-adrenergic receptors are associated with reduced cardiac function in chronic heart failure Circulation 99 649 654 9950662 1:CAS:528:DyaK1MXhtlSjs7k%3D (Pubitemid 29077363)
107. CJ Limas IF Goldenberg C Limas 1992 Assessment of immune modulation of beta-adrenergic pathways in human dilated cardiomyopathy: influence of methodologic factors Am Heart J 123 967 970 1312761 1:STN:280: DyaK387pslCktQ%3D%3D 10.1016/0002-8703(92)90704-Y
108. C Del Corsso AC de Carvalho HF Martino WA Varanda 2004 Sera from patients with idiopathic dilated cardiomyopathy decrease ICa in cardiomyocytes isolated from rabbits Am J Physiol Heart Circ Physiol 287 H1928 H1936 15256368 1:CAS:528:DC%2BD2cXhtVaqsbfJ 10.1152/ajpheart.00044.2004 (Pubitemid 39430727)
109. L Cervetta E Moretti B Basso 2002 Experimental Chagas' disease: the protection induced by immunization with Trypanosoma rangeli is associated with down-regulation of IL-6, TNF-α and IL-10 synthesis Acta Parasitol 47 73 78 1:CAS:528:DC%2BD38XlsF2iu78%3D (Pubitemid 34499853)
110. DR Pakianathan RE Kuhn 1992 Interleukin-2 receptors in experimental Chagas' disease Infect Immun 60 3904 3908 1500197 1:CAS:528:DyaK3sXlsVOk
111. N Medrano-Mercado MR Luz F Torrico G Tapia F Van Leuven TC Araujo-Jorge 1996 Acute-phase proteins and serologic profiles of chagasic children from an endemic area in Bolivia Am J Trop Med Hyg 54 154 161 8619440 1:STN:280:DyaK283gsFSjsw%3D%3D (Pubitemid 26083601)
112. NM Medrano MR Luz PH Cabello GT Tapia F Van Leuven TC Araújo-Jorge 1996 Acute Chagas' disease: plasma levels of alpha-2-macroglobulin and C-reactive protein in children under 13 years in a high endemic area of Bolivia J Trop Pediatr 42 68 74 8984217 1:STN:280:DyaK2s7gsFehtQ%3D%3D 10.1093/tropej/42.2.68 (Pubitemid 26123696)
113. JM Pascale CE Sousa A Orn 1991 Evaluation of interleukin-2 soluble receptor in patients with tripanosomiasis Americana in Panama Rev Med Panama 16 184 188 1767036 1:STN:280:DyaK387hsFyluw%3D%3D
114. JM Pascale OE Sousa A Orn 1992 Determination of soluble interleukin-2 receptor in patients with American trypanosomiasis in Panama Rev Med Panama 17 12 16 1603982 1:STN:280:DyaK383psVChug%3D%3D
115. E Moretti B Basso L Cervetta A Brigada G Barbieri 2002 Patterns of cytokines and soluble cellular receptors in the sera of children with acute Chagas' disease Clin Diagn Lab Immunol 9 1324 1327 12414768 1:CAS:528: DC%2BD38XptFakt7Y%3D (Pubitemid 35283298)
116. R Ramasawmy E Cunha-Neto KC Faé NG Müller VL Cavalcanti SA Drigo B Ianni C Mady J Kalil AC Goldberg 2006 BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy J Infect Dis 193 1394 1399 16619187 1:CAS:528:DC%2BD28Xlt1ejtbc%3D 10.1086/503368 (Pubitemid 43673387)
117. L López K Arai E Giménez M Jiménez C Pascuzo C Rodríguez-Bonfante R Bonfante-Cabarcas 2006 C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure Rev Esp Cardiol 59 50 56 16434004 10.1157/13083649 (Pubitemid 43285631)
118. Munoz Saravia SG, Haberland A, Bartel S, Araujo R, Valda G, Duchen D, Diaz Ramirez I, Borges AC, Wallukat G, Schimke I (2010) Cardiac troponin T measured with a highly sensitive assay for diagnosis and monitoring of heart injury in chronic Chagas' disease. Arch Pathol Lab Med (in press)
119. MS Cetron FP Basilio AP Moraes AQ Sousa JN Paes SJ Kahn MH Wener WC Van Voorhis 1993 Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection Am J Trop Med Hyg 49 370 382 8372959 1:STN:280:DyaK3szosVShsQ%3D%3D (Pubitemid 23289397)
120. AO Mocelin VS Issa F Bacal GV Guimarães E Cunha EA Bocchi 2005 The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy Eur J Heart Fail 7 869 873 16043406 1:CAS:528:DC%2BD2MXns1Wltrk%3D 10.1016/j.ejheart.2004.10.014 (Pubitemid 41125908)
121. RC Ferreira BM Ianni LC Abel P Buck C Mady J Kalil E Cunha-Neto 2003 Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/ "indeterminate" and Chagas disease cardiomyopathy patients Mem Inst Oswaldo Cruz 98 407 411 12886425 1:CAS:528:DC%2BD3sXls1Cmu70%3D 10.1590/S0074-02762003000300021 (Pubitemid 38030560)
122. R Pérez-Fuentes A López-Colombo G Ordóñez- Toquero I Gomez-Albino J Ramos E Torres-Rasgado H Salgado-Rosas M Romero-Díaz P Pulido-Pérez MC Sánchez-Guillén 2007 Correlation of the serum concentrations of tumour necrosis factor and nitric oxide with disease severity in chronic Chagas disease (American trypanosomiasis) Ann Trop Med Parasitol 101 123 132 17316498 10.1179/136485907X154593 1:CAS:528:DC%2BD2sXjvVOqsb0%3D (Pubitemid 47488160)
123. A Talvani MO Rocha LS Barcelos YM Gomes AL Ribeiro MM Teixeira 2004 Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy Clin Infect Dis 38 943 950 15034825 1:CAS:528: DC%2BD2cXjslGrsr0%3D 10.1086/381892 (Pubitemid 38457201)
124. DB Rodrigues D Correia MD Marra LE Giraldo E Lages-Silva ML Silva-Vergara CH Barata 2005 Rodrigues Junior V (2005) Cytokine serum levels in patients infected by human immunodeficiency virus with and without Trypanosoma cruzi coinfection Rev Soc Bras Med Trop 38 483 487 16410923 (Pubitemid 43169983)
125. I Dalle-Donne R Rossi R Colombo D Giustarini A Milzani 2006 Biomarkers of oxidative damage in human disease Clin Chem 52 601 623 16484333 1:CAS:528:DC%2BD28Xjt1Gruro%3D 10.1373/clinchem.2005.061408
126. D Giustarini I Dalle-Donne D Tsikas R Rossi D Giustarini 2009 Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers Crit Rev Clin Lab Sci 46 241 281 19958214 1:CAS:528:DC%2BD1MXhsFSqtL%2FN 10.3109/10408360903142326
127. FJ Giordano 2005 Oxygen, oxidative stress, hypoxia, and heart failure J Clin Invest 115 500 508 15765131 1:CAS:528:DC%2BD2MXit1emsL0%3D (Pubitemid 40322219)
128. TB de Oliveira RC Pedrosa DW Filho 2007 Oxidative stress in chronic cardiopathy associated with Chagas' disease Int J Cardiol 116 357 363 16859784 10.1016/j.ijcard.2006.04.046
129. Gupta S, Wen JJ, Garg NJ (2009) Oxidative stress in Chagas disease. Interdiscip Perspect Infect Dis 190354 [Epub 2009, Jun 14]
130. LB Maçao D Wilhelm Filho RC Pedrosa A Pereira P Backes MA Torres TS Fröde 2007 Antioxidant therapy attenuates oxidative stress in chronic cardiopathy associated with Chagas' disease Int J Cardiol 123 43 49 17328977 10.1016/j.ijcard.2006.11.118 (Pubitemid 350116976)
131. F Villalta F Kierszenbaum 1983 Role of polymorphonuclear cells in Chagas' disease. I. Uptake and mechanisms of destruction of intracellular (amastigote) forms of Trypanosoma cruzi by human neutrophils J Immunol 131 1504 1510 6309964 1:STN:280:DyaL3s3pt1Crsg%3D%3D (Pubitemid 13048914)
132. JA Smith 1994 Neutrophils, host defense, and inflammation: a double-edged sword J Leukoc Biol 56 672 686 7996043 1:CAS:528:DyaK2MXis1Kgtr0%3D
133. BM Babior 2000 Phagocytes and oxidative stress Am J Med 109 33 44 10936476 1:CAS:528:DC%2BD3cXlsFChsLg%3D 10.1016/S0002-9343(00)00481-2 (Pubitemid 30608735)
134. JJ Wen M Dhiman EB Whorton NJ Garg 2008 Tissue-specific oxidative imbalance and mitochondrial dysfunction during Trypanosoma cruzi infection in mice Microbes Infect 10 1201 1209 18675934 1:CAS:528:DC%2BD1cXht12rsLzK 10.1016/j.micinf.2008.06.013
135. AL Báez MS Lo Presti HW Rivarola P Pons R Fretes P Paglini-Oliva 2008 Trypanosoma cruzi: cardiac mitochondrial alterations produced by different strains in the acute phase of the infection Exp Parasitol 120 397 402 18848545 10.1016/j.exppara.2008.09.014 1:CAS:528:DC%2BD1cXhtlCru7bK
136. JJ Wen V Bhatia VL Popov NJ Garg 2006 Phenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease Am J Pathol 169 1953 1964 17148660 1:CAS:528:DC%2BD2sXhvV2hsA%3D%3D 10.2353/ajpath.2006.060475 (Pubitemid 351181957)
137. PE Palhares NS Marcondes P Fontana Júnior GM Schaeffer OM Bastos 1987 Correlation between tissue damage and malondialdehydemia in mice infected with Trypanosoma cruzi Braz J Med Biol Res 20 795 798 3137991 1:STN:280:DyaL1czislaisQ%3D%3D
138. PE Palhares NS Marcondes P Fontana Júnior GM Schaeffer OM Bastos 1987 Malondialdehydemia and parasitemia during acute phase of experimental Chagas' disease in mice Braz J Med Biol Res 20 799 801 3137992 1:STN:280:DyaL1czislaitg%3D%3D
139. PE Palhares P Fontana Júnior GM Schaffer NS Marcondes M Vergara 1988 Tissue damage markers in experimental Chagas' disease Braz J Med Biol Res 21 957 959 3150297 1:STN:280:DyaL1M3kvVWgsA%3D%3D
140. JJ Wen G Vyatkina N Garg 2004 Oxidative damage during chagasic cardiomyopathy development: role of mitochondrial oxidant release and inefficient antioxidant defense Free Radic Biol Med 37 1821 1833 15528041 1:CAS:528:DC%2BD2cXpsFWrsbw%3D 10.1016/j.freeradbiomed.2004.08.018 (Pubitemid 39441066)
141. Y Michowitz S Kisil H Guzner-Gur A Rubinstein D Wexler D Sheps G Keren J George 2008 Usefulness of serum myeloperoxidase in prediction of mortality in patients with severe heart failure Isr Med Assoc J 10 884 888 19160948
142. M Dhiman JG Estrada-Franco JM Pando FJ Ramirez-Aguilar H Spratt S Vazquez-Corzo G Perez-Molina R Gallegos-Sandoval R Moreno NJ Garg 2009 Increased myeloperoxidase activity and protein nitration are indicators of inflammation in patients with Chagas' disease Clin Vaccine Immunol 16 660 666 19297613 1:CAS:528:DC%2BD1MXotV2jtb4%3D 10.1128/CVI.00019-09
143. JJ Wen PC Yachelini A Sembaj RE Manzur NJ Garg 2006 Increased oxidative stress is correlated with mitochondrial dysfunction in chagasic patients Free Radic Biol Med 41 270 276 16814107 1:CAS:528:DC%2BD28Xmt1Orsbg%3D 10.1016/j.freeradbiomed.2006.04.009 (Pubitemid 44202395)
144. R Pérez-Fuentes JF Guégan C Barnabé A López-Colombo H Salgado-Rosas E Torres-Rasgado B Briones M Romero-Díaz J Ramos-Jiménez C Sánchez-Guillén Mdel 2003 Severity of chronic Chagas disease is associated with cytokine/antioxidant imbalance in chronically infected individuals Int J Parasitol 33 293 299 12670514 10.1016/S0020-7519(02)00283-7 1:CAS:528:DC%2BD3sXisFWnsLY%3D (Pubitemid 36369150)
145. R Pérez-Fuentes E Torres-Rasgado H Salgado-Rosas I Zamora-Ginez MC Sánchez-Guillén 2008 The anti-oxidant defence response in individuals with the indeterminate form of Chagas disease (American trypanosomiasis) Ann Trop Med Parasitol 102 189 197 18348773 10.1179/136485908X267858 1:CAS:528:DC%2BD1cXltl2kt7w%3D (Pubitemid 351767926)
146. MT Rivera AP de Souza AH Moreno SS Xavier JA Gomes MO Rocha R Correa-Oliveira J Nève J Vanderpas TC Araújo-Jorge 2002 Progressive Chagas' cardiomyopathy is associated with low selenium levels Am J Trop Med Hyg 66 706 712 12224578 (Pubitemid 35001042)
147. A Maisel C Mueller K Adams, et al. 2008 State of the art: using natriuretic peptide levels in clinical practice Eur J Heart Fail 10 824 839 18760965 1:CAS:528:DC%2BD1cXhtFaju7jO 10.1016/j.ejheart.2008.07.014
148. AL Ribeiro AM dos Reis MV Barros MR de Sousa AL Rocha AA Perez JB Pereira FS Machado MO Rocha 2002 Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease Lancet 360 461 462 12241721 1:CAS:528: DC%2BD38XlvF2ksbY%3D 10.1016/S0140-6736(02)09638-1 (Pubitemid 34880146)
149. A Talvani MO Rocha J Cogan P Maewal J de Lemos AL Ribeiro MM Teixeira 2004 Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy Mem Inst Oswaldo Cruz 99 645 649 15558179 1:CAS:528: DC%2BD2cXhtVSht7fK 10.1590/S0074-02762004000600020 (Pubitemid 39462958)
150. A Talvani MO Rocha J Cogan P Maewal J de Lemos AL Ribeiro MM Teixeira 2005 Brain natriuretic peptide measurement in Chagas heart disease: marker of ventricular dysfunction and arrhythmia Int J Cardiol 100 503 504 15837098 10.1016/j.ijcard.2004.06.007
151. RB Melo GB Parente EG Victor 2005 Measurement of human brain natriuretic peptide in patients with Chagaws disease Arq Bras Cardiol 84 137 140 15761636 10.1590/S0066-782X2005000200008 (Pubitemid 40385834)
152. F Vilas-Boas GS Feitosa MB Soares JA Pinho-Filho T Nascimento MM Barojas MV Andrade R Ribeiro-Dos-Santos E Bocchi 2008 Invasive and noninvasive correlations of B-type natriuretic peptide in patients with heart failure due to Chagas cardiomyopathy Congest Heart Fail 14 121 126 18550922 1:CAS:528:DC%2BD1cXotV2jtLw%3D 10.1111/j.1751-7133.2008.08166.x
153. DS Marques MF Canesin F Barutta Júnior CJ Fuganti AC Barretto 2006 Evaluation of asymptomatic patients with chronic Chagas disease through ambulatory electrocardiogram, echocardiogram and B-Type natriuretic peptide analyses Arq Bras Cardiol 87 336 343 17057935 10.1590/S0066-782X2006001600017
154. S Heringer-Walther MC Moreira N Wessel JL Saliba J Silvia-Barra JL Pena S Becker WE Siems HP Schultheiss T Walther 2005 Brain natriuretic peptide predicts survival in Chagas' disease more effectively than atrial natriuretic peptide Heart 91 385 387 15710733 1:CAS:528:DC%2BD2MXis1Chs7k%3D 10.1136/hrt.2003.026856 (Pubitemid 40299234)
155. C Moreira Mda S Heringer-Walther N Wessel T Moreira Ventura Y Wang HP Schultheiss T Walther 2008 Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation Cardiology 110 217 225 18073475 10.1159/000112403 1:CAS:528:DC%2BD1cXnvFSjtrc%3D (Pubitemid 351919786)
156. AL Ribeiro MM Teixeira AM Reis A Talvani AA Perez MV Barros MO Rocha 2006 Brain natriuretic peptide based strategy to detect left ventricular dysfunction in Chagas disease: a comparison with the conventional approach Int J Cardiol 109 34 40 16023747 10.1016/j.ijcard.2005.05.048
157. L Sousa FA Botoni RR Britto MO Rocha AL Teixeira Jr MM Teixeira AM Reis BM Oliveira AL Ribeiro 2008 Six-minute walk test in Chagas cardiomyopathy Int J Cardiol 125 139 141 17399822 10.1016/j.ijcard.2007.01.034 (Pubitemid 351305413)
158. MM Lima MC Nunes MO Rocha FR Beloti MC Alencar AL Ribeiro 2010 Left ventricular diastolic function and exercise capacity in patients with chagas cardiomyopathy Echocardiography 27 519 524 20412275 10.1111/j.1540-8175.2009. 01081.x
159. BM Oliveira FA Botoni AL Ribeiro AS Pinto AM Reis C Nunes Mdo MO Rocha 2009 Correlation between BNP levels and Doppler echocardiographic parameters of left ventricle filling pressure in patients with Chagasic cardiomyopathy Echocardiography 26 521 527 19452608 10.1111/j.1540-8175.2008.00842.x
160. F Fernandes S Dantas BM Ianni FJ Ramires P Buck VM Salemi HF Lopes C Mady 2007 Leptin levels in different forms of Chagas' disease Braz J Med Biol Res 40 1631 1636 17713658 1:CAS:528:DC%2BD1cXivFKjtro%3D 10.1590/S0100- 879X2006005000152
161. MM Barbosa C Nunes Mdo AL Ribeiro MM Barral MO Rocha 2007 N-terminal proBNP levels in patients with Chagas disease: a marker of systolic and diastolic dysfunction of the left ventricle Eur J Echocardiogr 8 204 212 16651029 10.1016/j.euje.2006.03.011 (Pubitemid 46657223)
162. C Mady F Fernandes E Arteaga FJ Ramires C Buck Pde VM Salemi BM Ianni L Nastari RR Dias 2008 Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies ArQ Bras Cardiol 91 46 50 18660945 10.1590/S0066-782X2008001300008
163. BM Scirica DA Morrow 2004 Troponins in acute coronary syndromes Prog Cardiovasc Dis 47 177 188 15736583 1:CAS:528:DC%2BD2MXhtFamsro%3D 10.1016/j.pcad.2004.07.004 (Pubitemid 40037317)
164. A Mingels L Jacobs E Michielsen J Swaanenburg W Wodzig M van Dieijen-Visser 2009 Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays Clin Chem 55 101 108 18988757 1:CAS:528:DC%2BD1MXptFaqtQ%3D%3D 10.1373/clinchem.2008.106427
165. AS Jaffe 2001 Elevation in cardiac troponin measurements: false false-positives Cardiovasc Toxicol 1 87 92 12213978 1:CAS:528: DC%2BD3MXotlCku7k%3D 10.1385/CT:1:2:087
166. A Jeremias CM Gibson 2005 Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded Ann Intern Med 142 786 791 15867411 (Pubitemid 40593781)
167. O Schulz K Kirpal J Stein R Bensch G Berghöfer I Schimke AS Jaffe 2006 Importance of low concentrations of cardiac troponins Clin Chem 52 1614 1615 16873305 1:CAS:528:DC%2BD28XnvFahtbs%3D 10.1373/clinchem.2006.071498 (Pubitemid 44148334)
168. SG Saravia F Knebel S Schroeckh R Ziebig A Lun A Weimann A Haberland AC Borges I Schimke 2010 Cardiac troponin T release and inflammation demonstrated in marathon runners Clin Lab 56 51 58 20380359 1:CAS:528:DC%2BC3cXmt1egtLc%3D
169. AL Basquiera R Capra M Omelianiuk M Amuchástegui RJ Madoery OA Salomone 2003 Serum troponin T in patients with chronic Chagas disease Rev Esp Cardiol 56 742 744 12855159 10.1157/13049658 (Pubitemid 36958247)
170. R Arias C Bastos G Mota F Sodré A Moreira A Tavares JC Lima 2003 Troponin in Chagas disease Braz J Infect Dis 7 358 359 14636473 10.1590/S1413-86702003000600001
171. MN Machado FA Suzuki OC Mouco ME Hernandes MA Lemos LN Maia 2005 Positive troponin T in a chagasic patient with sustained ventricular tachycardia and no obstructive lesions on cine coronary angiography Arq Bras Cardiol 84 182 184 15761647 10.1590/S0066-782X2005000200019 (Pubitemid 40385845)